- Home
- BKTI vs PRQR Comparison
BKTI vs PRQR Comparison
Compare BKTI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKTI
- PRQR
- Stock Information
- Founded
- BKTI 1997
- PRQR 2012
- Country
- BKTI United States
- PRQR Netherlands
- Employees
- BKTI N/A
- PRQR N/A
- Industry
- BKTI Radio And Television Broadcasting And Communications Equipment
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- BKTI Technology
- PRQR Health Care
- Exchange
- BKTI Nasdaq
- PRQR Nasdaq
- Market Cap
- BKTI 156.7M
- PRQR 179.1M
- IPO Year
- BKTI N/A
- PRQR 2014
- Fundamental
- Price
- BKTI $42.54
- PRQR $1.77
- Analyst Decision
- BKTI Strong Buy
- PRQR Strong Buy
- Analyst Count
- BKTI 1
- PRQR 7
- Target Price
- BKTI $55.00
- PRQR $9.00
- AVG Volume (30 Days)
- BKTI 25.8K
- PRQR 305.8K
- Earning Date
- BKTI 05-13-2025
- PRQR 08-07-2025
- Dividend Yield
- BKTI N/A
- PRQR N/A
- EPS Growth
- BKTI N/A
- PRQR N/A
- EPS
- BKTI 2.59
- PRQR N/A
- Revenue
- BKTI $77,415,000.00
- PRQR $21,212,711.00
- Revenue This Year
- BKTI $8.80
- PRQR $2.87
- Revenue Next Year
- BKTI $8.69
- PRQR N/A
- P/E Ratio
- BKTI $16.76
- PRQR N/A
- Revenue Growth
- BKTI 5.18
- PRQR 85.91
- 52 Week Low
- BKTI $11.67
- PRQR $1.07
- 52 Week High
- BKTI $48.43
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- BKTI 46.66
- PRQR 54.41
- Support Level
- BKTI $42.85
- PRQR $1.75
- Resistance Level
- BKTI $46.40
- PRQR $1.96
- Average True Range (ATR)
- BKTI 2.31
- PRQR 0.10
- MACD
- BKTI -0.28
- PRQR 0.00
- Stochastic Oscillator
- BKTI 14.12
- PRQR 38.71
About BKTI BK Technologies Corporation
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.